• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙一座中等规模城市的一家地区医院的一项研究表明,耐碳青霉烯类细菌的感染/定植大幅增加,这与新冠疫情同时发生。

A Study in a Regional Hospital of a Mid-Sized Spanish City Indicates a Major Increase in Infection/Colonization by Carbapenem-Resistant Bacteria, Coinciding with the COVID-19 Pandemic.

作者信息

Cano-Martín Estefanía, Portillo-Calderón Inés, Pérez-Palacios Patricia, Navarro-Marí José María, Fernández-Sierra María Amelia, Gutiérrez-Fernández José

机构信息

Department of Preventive Medicine and Public Health, Virgen de las Nieves University Hospital & ibs, Granada-Instituto de Investigación Biosanitaria de Granada, Avda. de las Fuerzas Armadas, 2, 18014 Granada, Spain.

Unidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología Clínica, Hospital Universitario Virgen Macarena & Instituto de Biomedicina de Sevilla (IBIs), Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41020 Sevilla, Spain.

出版信息

Antibiotics (Basel). 2021 Sep 18;10(9):1127. doi: 10.3390/antibiotics10091127.

DOI:10.3390/antibiotics10091127
PMID:34572709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8469839/
Abstract

Bacterial resistance to antibiotics has proven difficult to control over the past few decades. The large group of multidrug-resistant bacteria includes carbapenemase-producing bacteria (CPB), for which limited therapeutic options and infection control measures are available. Furthermore, carbapenemases associate with high-risk clones that are defined by the sequence type (ST) to which each bacterium belongs. The objectives of this cross-sectional and retrospective study were to describe the CPB population isolated in a third-level hospital in Southern Spain between 2015 and 2020 and to establish the relationship between the ST and the epidemiological situation defined by the hospital. CPB were microbiologically studied in all rectal and pharyngeal swabs and clinical samples received between January 2015 and December 2020, characterizing isolates using MicroScan and mass spectrometry. Carbapenemases were detected by PCR and Sanger sequencing, and STs were assigned by multilocus sequence typing (MLST). Isolates were genetically related by pulsed-field gel electrophoresis using Xbal, Spel, or Apal enzymes. The episodes in which each CPB was isolated were recorded and classified as involved or non-involved in an outbreak. There were 320 episodes with CPB during the study period: 18 with , 14 with , 9 with , 11 with , 46 with , 70 with , and 52 with . The carbapenemase groups detected were OXA, VIM, KPC, and NDM with various subgroups. Synchronous relationships were notified between episodes of and outbreaks for ST15, ST258, ST307, and ST45, but not for the other CPB. There was a major increase in infections with CPB over the years, most notably during 2020, coinciding with the COVID-19 pandemic. This study highlights the usefulness of gene sequencing techniques to control the spread of these microorganisms, especially in healthcare centers. These techniques offer faster results, and a reduction in their cost may make their real-time application more feasible. The combination of epidemiological data with real-time molecular sequencing techniques can provide a major advance in the transmission control of these CPB and in the management of infected patients. Real-time sequencing is essential to increase precision and thereby control outbreaks and target infection prevention measures in a more effective manner.

摘要

在过去几十年中,事实证明,细菌对抗生素的耐药性很难控制。大量的多重耐药细菌包括产碳青霉烯酶细菌(CPB),针对这类细菌,可用的治疗选择和感染控制措施有限。此外,碳青霉烯酶与高风险克隆相关联,这些克隆由每种细菌所属的序列类型(ST)定义。这项横断面回顾性研究的目的是描述2015年至2020年期间在西班牙南部一家三级医院分离出的CPB群体,并确定ST与医院定义的流行病学情况之间的关系。对2015年1月至2020年12月期间收到的所有直肠和咽拭子以及临床样本中的CPB进行微生物学研究,使用MicroScan和质谱对分离株进行特征分析。通过PCR和桑格测序检测碳青霉烯酶,并通过多位点序列分型(MLST)指定STs。使用Xbal、Spel或Apal酶通过脉冲场凝胶电泳确定分离株的遗传相关性。记录每个CPB分离的事件,并将其分类为与暴发有关或无关。研究期间有320起CPB事件:18起为[具体菌株1],14起为[具体菌株2],9起为[具体菌株3],11起为[具体菌株4],46起为[具体菌株5],70起为[具体菌株6],52起为[具体菌株7]。检测到的碳青霉烯酶组为OXA、VIM、KPC和NDM以及各种亚组。对于ST15、ST258、ST307和ST45,[具体菌株1]事件与暴发之间存在同步关系,但其他CPB不存在这种关系。这些年来,CPB感染大幅增加,最显著的是在2020年,与COVID-19大流行同时发生。这项研究强调了基因测序技术在控制这些微生物传播方面的有用性,特别是在医疗保健中心。这些技术能提供更快的结果,降低其成本可能会使其实时应用更可行。将流行病学数据与实时分子测序技术相结合,可以在这些CPB的传播控制和感染患者的管理方面取得重大进展。实时测序对于提高精确度从而控制暴发并更有效地针对感染预防措施至关重要。

相似文献

1
A Study in a Regional Hospital of a Mid-Sized Spanish City Indicates a Major Increase in Infection/Colonization by Carbapenem-Resistant Bacteria, Coinciding with the COVID-19 Pandemic.西班牙一座中等规模城市的一家地区医院的一项研究表明,耐碳青霉烯类细菌的感染/定植大幅增加,这与新冠疫情同时发生。
Antibiotics (Basel). 2021 Sep 18;10(9):1127. doi: 10.3390/antibiotics10091127.
2
[Infections in patients colonized with carbapenem-resistant Gram-negative bacteria in a medium Spanish city].[西班牙一座中等规模城市中耐碳青霉烯革兰氏阴性菌定植患者的感染情况]
Rev Esp Quimioter. 2021 Oct;34(5):450-458. doi: 10.37201/req/021.2021. Epub 2021 Jun 8.
3
A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.在五家哥伦比亚三级护理医院进行的为期两年的监测显示,耐碳青霉烯类肺炎克雷伯菌的非CG258克隆株出现频率较高,且具有不同的临床特征。
Antimicrob Agents Chemother. 2015 Oct 26;60(1):332-42. doi: 10.1128/AAC.01775-15. Print 2016 Jan.
4
Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital.保加利亚一家医院中携带碳青霉烯酶NDM-1、VIM-1和OXA-23/72的革兰氏阴性菌的克隆传播
Microb Drug Resist. 2017 Apr;23(3):301-307. doi: 10.1089/mdr.2016.0059. Epub 2016 Jul 26.
5
Early OXA-48-Producing Isolates Recovered in a Spanish Hospital Reveal a Complex Introduction Dominated by Sequence Type 11 (ST11) and ST405 Klebsiella pneumoniae Clones.西班牙某医院分离到的早期产 OXA-48 菌株揭示了 11 型(ST11)和 ST405 型肺炎克雷伯菌克隆主导的复杂传播途径。
mSphere. 2020 Apr 8;5(2):e00080-20. doi: 10.1128/mSphere.00080-20.
6
A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.西班牙马德里长期护理医院产碳青霉烯酶肠杆菌科细菌粪便携带者的单日现况研究描绘了其复杂的克隆和多克隆传播情况。
J Antimicrob Chemother. 2016 Feb;71(2):348-52. doi: 10.1093/jac/dkv355. Epub 2015 Oct 30.
7
Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia.俄罗斯圣彼得堡产碳青霉烯酶革兰阴性菌的出现。
Int J Antimicrob Agents. 2014 Aug;44(2):152-5. doi: 10.1016/j.ijantimicag.2014.05.004. Epub 2014 Jun 12.
8
Genetic Diversity of Carbapenem-Resistant (CRE) Clinical Isolates From a Tertiary Hospital in Eastern China.中国东部一家三级医院耐碳青霉烯类肠杆菌科细菌(CRE)临床分离株的遗传多样性
Front Microbiol. 2019 Jan 15;9:3341. doi: 10.3389/fmicb.2018.03341. eCollection 2018.
9
Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.也门萨那 Al Thawra 大学医院耐碳青霉烯肠杆菌科临床分离株的特征。
Microb Drug Resist. 2020 Mar;26(3):211-217. doi: 10.1089/mdr.2018.0443. Epub 2019 Aug 9.
10
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).碳青霉烯类耐药肠杆菌科的表型和基因型特征:来自中国一项纵向大规模 CRE 研究的数据(2012-2016 年)。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205. doi: 10.1093/cid/ciy660.

引用本文的文献

1
Development and Validation of a Multiplex Real-Time PCR Assay for Rapid Screening of Main Carbapenemase Genes in Clinical Isolates and Surveillance Samples.用于临床分离株和监测样本中主要碳青霉烯酶基因快速筛查的多重实时PCR检测方法的建立与验证
Antibiotics (Basel). 2025 Apr 1;14(4):363. doi: 10.3390/antibiotics14040363.
2
Genomic Characterization of NDM-1 Harboring Extensively-Drug Resistance Isolate From ICU-Admitted Patient With COVID-19.从一名入住重症监护病房的新冠肺炎患者中分离出的携带NDM-1的广泛耐药菌株的基因组特征分析
J Trop Med. 2025 Apr 14;2025:6616950. doi: 10.1155/jotm/6616950. eCollection 2025.
3
Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis.2019年冠状病毒病大流行和抗菌药物管理对医院感染中抗菌药物耐药性的多重影响:一项中断时间序列分析
Front Public Health. 2024 Jul 17;12:1419344. doi: 10.3389/fpubh.2024.1419344. eCollection 2024.
4
International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe.欧洲耐碳青霉烯类肺炎克雷伯菌的国际和地区传播。
Nat Commun. 2024 Jun 14;15(1):5092. doi: 10.1038/s41467-024-49349-z.
5
Reliability of a Screening Method Using Antibiotic Disks to Detect Carbapenemases in Glucose-Nonfermenting Gram-Negative Microorganisms From Clinical Samples of a Regional Hospital in Southeastern Spain.使用抗生素纸片筛查法检测西班牙东南部地区医院临床样本中葡萄糖非发酵革兰氏阴性微生物碳青霉烯酶的可靠性。
J Clin Lab Anal. 2024 Apr;38(8):e25036. doi: 10.1002/jcla.25036. Epub 2024 Apr 15.
6
Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.从某些利比亚医院收治的免疫功能低下的 SARS-CoV-2 患者定植的碳青霉烯类和多黏菌素耐药革兰氏阴性菌中分离出。
Microbiol Spectr. 2023 Jun 15;11(3):e0297222. doi: 10.1128/spectrum.02972-22. Epub 2023 Apr 12.
7
Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital.一组新冠肺炎患者中的细菌和真菌合并感染及二重感染:来自意大利一家三级医院的真实数据。
Infect Dis Rep. 2022 May 12;14(3):372-382. doi: 10.3390/idr14030041.
8
Systematic Review of Plasmid AmpC Type Resistances in and and Preliminary Proposal of a Simplified Screening Method for .关于[具体内容1]和[具体内容2]中质粒AmpC型耐药性的系统评价及[具体内容3]简化筛选方法的初步建议
Microorganisms. 2022 Mar 14;10(3):611. doi: 10.3390/microorganisms10030611.

本文引用的文献

1
The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network.2019 年冠状病毒病(COVID-19)对 2020 年医疗机构相关感染的影响:国家医疗保健安全网络报告数据摘要。
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25. doi: 10.1017/ice.2021.362. Epub 2021 Sep 3.
2
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation.辅助机械通气患者中 SARS-CoV2 感染和多药耐药菌合并感染的动力学。
Front Cell Infect Microbiol. 2021 Aug 12;11:683409. doi: 10.3389/fcimb.2021.683409. eCollection 2021.
3
Antibiotic resistance during and beyond COVID-19.新冠疫情期间及之后的抗生素耐药性
JAC Antimicrob Resist. 2021 Jun 15;3(Suppl 1):i5-i16. doi: 10.1093/jacamr/dlab052. eCollection 2021 Jun.
4
[Infections in patients colonized with carbapenem-resistant Gram-negative bacteria in a medium Spanish city].[西班牙一座中等规模城市中耐碳青霉烯革兰氏阴性菌定植患者的感染情况]
Rev Esp Quimioter. 2021 Oct;34(5):450-458. doi: 10.37201/req/021.2021. Epub 2021 Jun 8.
5
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID.新冠疫情时代不适当的抗生素使用:与不适当处方及继发并发症相关的因素。SEMI-COVID登记研究分析
PLoS One. 2021 May 11;16(5):e0251340. doi: 10.1371/journal.pone.0251340. eCollection 2021.
6
Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade.过去十年中,在地中海东部地区,耐碳青霉烯类革兰氏阴性杆菌的流行情况和分子流行病学,以及它们的耐药决定因子。
J Glob Antimicrob Resist. 2021 Jun;25:209-221. doi: 10.1016/j.jgar.2021.02.033. Epub 2021 Apr 1.
7
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales.亚胺培南/雷巴他定对西班牙全国产碳青霉烯酶肠杆菌科的活性。
J Antimicrob Chemother. 2021 May 12;76(6):1498-1510. doi: 10.1093/jac/dkab043.
8
OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance.西班牙医院中产生OXA-48碳青霉烯酶的肠杆菌目细菌:关于日益增长的抗菌药物耐药性的最新综合综述
Antibiotics (Basel). 2021 Jan 18;10(1):89. doi: 10.3390/antibiotics10010089.
9
Antimicrobial Resistance and Genomic Characterization of OXA-48- and CTX-M-15-Co-Producing Hypervirulent ST23 Recovered from Nosocomial Outbreak.从医院感染暴发中分离出的产OXA-48和CTX-M-15的高毒力ST23菌株的耐药性及基因组特征分析
Antibiotics (Basel). 2020 Dec 3;9(12):862. doi: 10.3390/antibiotics9120862.
10
Emergence of carbapenem-resistant ST131 carrying in Germany, 2019 to 2020.2019 至 2020 年德国出现携带碳青霉烯酶耐药基因 ST131 的 ……
Euro Surveill. 2020 Nov;25(46). doi: 10.2807/1560-7917.ES.2020.25.46.2001815.